Adriamycin treatment increases 3-hydroxy-3-methylglutaryl CoA reductase and isoprene biosynthesis in the rat liver.
D000818:Animals; D002070:Butadienes / Q000096:biosynthesis*; D002784:Cholesterol / Q000378:metabolism; D004317:Doxorubicin / Q000494:pharmacology*; D045782:Hemiterpenes; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism*; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology; D010420:Pentanes; D051381:Rats; D014451:Ubiquinone / Q000378:metabolism
D002070:Butadienes; D045782:Hemiterpenes; D010420:Pentanes; C005059:isoprene; D014451:Ubiquinone; D004317:Doxorubicin; D002784:Cholesterol; D006903:Hydroxymethylglutaryl CoA Reductases